v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Activities:    
Net loss $ (85,566) $ (103,567)
Adjustments to reconcile net loss to cash used in operating activities    
Depreciation, amortization, and non-cash lease interest 12,026 12,670
Allowance for expected credit losses 646 (688)
Provision for excess and obsolete inventory 1,521 305
Change in fair value of derivative liabilities (189) 426
Change in fair value of contingent earnout liability 3,658 (1,036)
Amortization (accretion) of (discounts) premiums on available-for-sale securities 0 (1,913)
Stock-based compensation expense 11,975 13,987
Loss on disposal of fixed assets 441 0
Gain on operating lease termination (973) 0
Long-lived asset impairment 0 4,015
Goodwill impairment 0 29,467
Foreign exchange (gains) losses on intercompany transactions, net (10) (75)
Changes in operating assets and liabilities    
Accounts receivable 2,712 5,967
Inventory 2,547 (529)
Prepaid expenses 49 107
Other current assets (30) 1,321
Other assets 209 (635)
Accounts payable and accrued expenses 1,636 (862)
Other current liabilities (168) 26
Deferred revenue (1,096) 648
Other long term liabilities (1,405) (669)
Other non-current lease liabilities (9,266) (7,865)
Net cash provided by (used in) operating activities (61,283) (48,900)
Investing Activities:    
Purchases of property and equipment (1,426) (3,591)
Proceeds from the sale of property, plant and equipment 0 37
Purchases of available-for-sale securities 0 (18,950)
Proceeds from sales and maturities of marketable securities 0 64,602
Net cash provided by (used in) investing activities (1,426) 42,098
Financing Activities:    
Payment of acquisition-related contingent liabilities (582) 0
Acquisition holdback payment 0 (250)
Proceeds from the exercise of common stock options 0 187
Taxes paid related to net share settlement of equity awards (574) (457)
Net cash provided by (used in) provided by financing activities (1,156) (520)
Effect of exchange rate changes on cash 15 (66)
Net change in cash, cash equivalents, and restricted cash (63,850) (7,388)
Cash, cash equivalents, and restricted cash    
Beginning of year 118,284 125,672
End of period 54,434 118,284
Supplemental disclosure of cash flow information    
Cash and cash equivalents 53,629 116,854
Restricted cash in other non-current assets 805 1,430
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows 54,434 118,284
Non cash financing and investing activities    
Common stock issued in connection with acquisition earnout achievement 750 0
Purchase of property and equipment in accounts payable and accrued expenses 4 325
Acquisition of cross license 5,474 0
Common stock disbursed to settle acquisition holdback $ 0 $ 250

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL